https://www.selleckchem.com/products/7acc2.html
The tocilizumab has been administered to control cytokine storms that occurred due to the release of proinflammatory cytokine including interleukin 6. Chloroquine and hydroxychloroquine were also used in hospitals, to handle severe COVID-19 patients. Currently, plasma therapy has been exercised as a therapeutic alternative, especially to handle severe COVID-19 patients. In addition, herbal medicines are expected to play significant role in the control and prevention of COVID-19. All these therapeutic options have their advantages and limi
Curtir
Comentario
Compartilhar
